Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models

This study aims to explore the relationships between renal function, hypoxia, and oxidative stress in chronic kidney disease (CKD). Seventy-six non-dialysis patients with CKD stages 1-5 and eight healthy subjects were included in the clinical research. They were divided into three groups: healthy s...

Full description

Bibliographic Details
Main Authors: Yizeng Xu, Fang Lu, Meng Wang, Lingchen Wang, Chaoyang Ye, Shuohui Yang, Chen Wang
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-03-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/10257
_version_ 1797228770308915200
author Yizeng Xu
Fang Lu
Meng Wang
Lingchen Wang
Chaoyang Ye
Shuohui Yang
Chen Wang
author_facet Yizeng Xu
Fang Lu
Meng Wang
Lingchen Wang
Chaoyang Ye
Shuohui Yang
Chen Wang
author_sort Yizeng Xu
collection DOAJ
description This study aims to explore the relationships between renal function, hypoxia, and oxidative stress in chronic kidney disease (CKD). Seventy-six non-dialysis patients with CKD stages 1-5 and eight healthy subjects were included in the clinical research. They were divided into three groups: healthy subjects, CKD stages 1-3, and CKD stages 4-5. In the animal study, 16 rat models of CKD were established through 5/6 renal ablation/infarction (A/I) surgery, and 8 normal rats were split into 3 groups: Sham, CKD, and losartan groups. Blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) was used to measure cortical and medullary T2* values (COT2* and MET2*) in all subjects and rats to evaluate renal oxygenation. Biochemical indicators were used to assess renal function and antioxidant capacity. Furthermore, the effects of losartan on renal fibrosis, hypoxia, and oxidative stress were examined using immunoblotting, colorimetric, and fluorometric assays. The results demonstrated significant positive associations between COT2* and MET2* with estimated glomerular filtration rate (eGFR). Patients with CKD stages 4-5 showed significantly lower serum superoxide dismutase (SOD) levels, which also had positive correlations with eGFR, COT2*, and MET2*. Furthermore, losartan treatment resulted in improved renal function and fibrosis, leading to increased levels of COT2*, MET2*, and SOD levels in 5/6 A/I rats. This was accompanied by reduced levels of hypoxia-inducible factor-1 alpha (HIF-1α) and malondialdehyde. Furthermore, losartan restored the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1), and suppressed the expression of Kelch-like ECH-associated protein 1 (Keap1) in 5/6 A/I kidneys. The study indicates that decline in renal oxygenation and antioxidant capacity is associated with the severity of renal failure in CKD. Losartan can potentially alleviate renal hypoxia and oxidative stress in the treatment of CKD via Keap1-Nrf2/HO-1 pathway.
first_indexed 2024-04-24T15:01:58Z
format Article
id doaj.art-5b2c593e9e284ea293b4e963c416a535
institution Directory Open Access Journal
issn 2831-0896
2831-090X
language English
last_indexed 2024-04-24T15:01:58Z
publishDate 2024-03-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj.art-5b2c593e9e284ea293b4e963c416a5352024-04-02T14:48:50ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2024-03-0110.17305/bb.2024.10257Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal modelsYizeng Xu0https://orcid.org/0000-0001-6612-9470Fang Lu1Meng Wang2Lingchen Wang3Chaoyang Ye4Shuohui Yang5https://orcid.org/0000-0002-2866-9529Chen Wang6Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China; Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, China; TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Radiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China; Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, China; TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China; Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, China; TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China; Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, China; TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Radiology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China; Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, China; TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China This study aims to explore the relationships between renal function, hypoxia, and oxidative stress in chronic kidney disease (CKD). Seventy-six non-dialysis patients with CKD stages 1-5 and eight healthy subjects were included in the clinical research. They were divided into three groups: healthy subjects, CKD stages 1-3, and CKD stages 4-5. In the animal study, 16 rat models of CKD were established through 5/6 renal ablation/infarction (A/I) surgery, and 8 normal rats were split into 3 groups: Sham, CKD, and losartan groups. Blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) was used to measure cortical and medullary T2* values (COT2* and MET2*) in all subjects and rats to evaluate renal oxygenation. Biochemical indicators were used to assess renal function and antioxidant capacity. Furthermore, the effects of losartan on renal fibrosis, hypoxia, and oxidative stress were examined using immunoblotting, colorimetric, and fluorometric assays. The results demonstrated significant positive associations between COT2* and MET2* with estimated glomerular filtration rate (eGFR). Patients with CKD stages 4-5 showed significantly lower serum superoxide dismutase (SOD) levels, which also had positive correlations with eGFR, COT2*, and MET2*. Furthermore, losartan treatment resulted in improved renal function and fibrosis, leading to increased levels of COT2*, MET2*, and SOD levels in 5/6 A/I rats. This was accompanied by reduced levels of hypoxia-inducible factor-1 alpha (HIF-1α) and malondialdehyde. Furthermore, losartan restored the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1), and suppressed the expression of Kelch-like ECH-associated protein 1 (Keap1) in 5/6 A/I kidneys. The study indicates that decline in renal oxygenation and antioxidant capacity is associated with the severity of renal failure in CKD. Losartan can potentially alleviate renal hypoxia and oxidative stress in the treatment of CKD via Keap1-Nrf2/HO-1 pathway. https://www.bjbms.org/ojs/index.php/bjbms/article/view/10257Renal hypoxiaoxidative stresschronic kidney diseaseblood oxygenation level-dependent magnetic resonance imaging
spellingShingle Yizeng Xu
Fang Lu
Meng Wang
Lingchen Wang
Chaoyang Ye
Shuohui Yang
Chen Wang
Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models
Biomolecules & Biomedicine
Renal hypoxia
oxidative stress
chronic kidney disease
blood oxygenation level-dependent magnetic resonance imaging
title Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models
title_full Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models
title_fullStr Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models
title_full_unstemmed Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models
title_short Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models
title_sort linking renal hypoxia and oxidative stress in chronic kidney disease based on clinical subjects and animal models
topic Renal hypoxia
oxidative stress
chronic kidney disease
blood oxygenation level-dependent magnetic resonance imaging
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/10257
work_keys_str_mv AT yizengxu linkingrenalhypoxiaandoxidativestressinchronickidneydiseasebasedonclinicalsubjectsandanimalmodels
AT fanglu linkingrenalhypoxiaandoxidativestressinchronickidneydiseasebasedonclinicalsubjectsandanimalmodels
AT mengwang linkingrenalhypoxiaandoxidativestressinchronickidneydiseasebasedonclinicalsubjectsandanimalmodels
AT lingchenwang linkingrenalhypoxiaandoxidativestressinchronickidneydiseasebasedonclinicalsubjectsandanimalmodels
AT chaoyangye linkingrenalhypoxiaandoxidativestressinchronickidneydiseasebasedonclinicalsubjectsandanimalmodels
AT shuohuiyang linkingrenalhypoxiaandoxidativestressinchronickidneydiseasebasedonclinicalsubjectsandanimalmodels
AT chenwang linkingrenalhypoxiaandoxidativestressinchronickidneydiseasebasedonclinicalsubjectsandanimalmodels